The 2023 Collaboration Awards goes to UK Citizens' Jury on Human Embryo Editing, led by Professor Anna Middleton, Director Kavli Centre for Ethics, Science, and the Public.
DNA analysis of thousands of tumours from NHS patients has found a ‘treasure trove’ of clues about the causes of cancer, with genetic mutations providing a personal history of the damage and repair processes each patient has been through.
Cambridge spin-out Zetta Genomics has raised £2.5 million in new seed funding from Nina Capital, APEX Medical and Cambridge Enterprise to advance its genomic data management technology and power the discovery and delivery of precision medicine at scale.
Whole genome sequencing from a single blood test picks up 31% more cases of rare genetic disorders than standard tests, shortening the ‘diagnostic odyssey’ that affected families experience, and providing huge opportunities for future research.
A new way to identify tumours that could be sensitive to particular immunotherapies has been developed using data from thousands of NHS cancer patient samples sequenced through the 100,000 Genomes Project.
Mitochondria, the ‘batteries’ that produce our energy, interact with the cell’s nucleus in subtle ways previously unseen in humans, according to research published today in the journal Science.